NOS3 (Q54930921)

From Wikidata

Jump to navigation Jump to search

cell line

Nagoya Ovarian Serous 3

Language	Label	Description	Also known as
English	NOS3	cell line	Nagoya Ovarian Serous 3

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells.

1 reference

Cellosaurus release 49

14 July 2024

Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro

1 reference

Cellosaurus release 49

14 July 2024

Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.

1 reference

Cellosaurus release 49

14 July 2024

Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

ovarian serous cystadenoma

1 reference

Cellosaurus release 26

12 June 2018

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54930921&oldid=2258516236"